https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society Crepnigauthor: *Corresponding Abbreviations: glands sperm- sweat where the and males, clogged; intestines; become in and ducts digestive especially carrying gallbladder the – liver, lungs; system and reproductive following: pancreas, sinuses the – – including system affect system systems can respiratory body fact the cells and This of out organs thickened. and becomes many in water mucus and altered, salt is mucus-making of and movement the water As salt, cells. body’s by the characterized in disease abnormality inherited an an is (CF) fibrosis Cystic Slobodianik H. N. Society g Nutrition the of Proceedings h uhr 00Frtpbihdoln 4Jn 2010 June 14 online published First 2010 Authors The https://www.cambridge.org/core 1 eateto urto n odSine colo hrayadBohmsr,Uiest fBeo Aires, Buenos of University Biochemistry, and Pharmacy of School Science, Food and Nutrition of Department namtr imre rfiei hlrnwt ytcfibrosis: cystic with children in profile biomarker Inflammatory h r nentoa muourto okhpwshl tPaj ’r,Grn,Sano 12 coe 2009 October 21–24 on Spain Girona, D’Aro, Platja at held was Workshop Immunonutrition International 3rd The F ytcfirss p euolsi;TC oa nixdn aaiy T,transthyretin. TTR, capacity; antioxidant total TAC, ceruloplasmin; Cp, fibrosis; cystic CF, eso :Deaysrtge opeetadmitigate and prevent to strategies Dietary 4: Session ehglgtd h A (m TAC The highlighted. be eesi h al urtoa ttseauto nC ainsi re oueappropriate and use survival to their order improve in to patients consequently CF in and para- life. functional evaluation therapies of system. and status quality pharmacological immune biochemical nutritional include the and to early of would nutritional need depression the concentration the the Cp in explain explain plasma meters could could increased results and an preliminary status with These concomitant inflammatory TAC the diminished exacerbate The RG. in lbnlvl eesoni ainsta nR.Tefc ht2 n 0 fptet exceeded patients of 50% and 23 that ( hapto- plasma fact fibrinogen and The low for RG. Cp towards values in higher than desirable tendency However, patients (reference the in status. the children shown nutritional were and healthy abnormal levels from concentration globin assay. an obtained suggested transferrin data decolorization values decreased with transthyretin a comparison The in by RG). immunodiffusion patients group, determined radial CF Service in Student’s single was Nutrition the lower the by by were (TAC) boys performed at measured were capacity (12 assisted analyses were haptoglobin, were Statistical antioxidant children (Cp), fibrinogen who Total nonhospitalized ceruloplasmin years, and transthyretin, 10 techniques. 17 (CRP) Transferrin, to on protein Hospital. months Elizalde 3 C-reactive performed de aged was from CF Pedro suffering inflammation with from study children to in girls) The capacity, related 5 antioxidant proteins, and (CF). total specific to fibrosis as determine well to cystic as was status study nutritional and preliminary process this of aim The . ytcfirss hlrn iceia aaees rtis oa nixdn capacity antioxidant Total Proteins: parameters: Biochemical Children: fibrosis: Cystic https://doi.org/10.1017/S0029665110001771 rN .Sooink fax Slobodianik, H. N. Dr 1 * .S Feliu S. M. , 2 urto evc,Pdod lzleHsia,Beo ie,Argentina Aires, Buenos Hospital, Elizalde de Pedro Service, Nutrition r nentoa muourto Workshop Immunonutrition International 3rd . IPaddress: (2010), 170.106.40.219 1 .Perris P. , 69 namtr diseases inflammatory 5–5 doi:10.1017/S0029665110001771 354–356 , + M 41 6 23 mi [email protected] email 8243, 964 4 11 54 rlxeuvlns a hw ob oe nteC ru than group CF the in lower be to shown was equivalents) Trolox ; rlmnr study preliminary , on 26 Sep2021 at04:15:58 (1) un ie,Argentina Aires, Bueno < 1 . .Barbeito S. , 285 . gd)adCP( CRP and mg/dl) 0 nye stemi as fpo rwh at diarrhoea fatty vitamins growth, fat-soluble poor in of deficiency cause and main pancreatic the vul- of is the increased secretion enzymes Diminished and in infections. movements of to fat bowel impairment nerability growth, greasy and slow gain, digestion, nutrients weight poor to essential leading of gut, absorption normal fC,priual nifnswt hi ihenergy high their with infants in particularly CF, of , subjectto theCambridgeCore termsofuse,available at t ncide ihC,ti uu a lopeetthe prevent also can mucus this CF, with children In urto ly nesnilrl ntemanagement the in role essential an plays Nutrition 2 et rnfri n rntyei values transthyretin and Transferrin test. .Strasnoy I. , < 0 . gd) epciey should respectively, mg/dl), 2 2 .Franchello A. , 2 (2,3) n .Ferraro M. and . 2 https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society A (m TAC D 28 HDL ple oC ainshv nrae hi uvvland survival their increased have life of patients quality dec- CF support few nutritional to last and applied the measures During treatment intake. improved require- ades, oral nutritional decreased high and expenditure, ments energy increased by nryiblnewt nrae ossadunachieved an and to losses due increased requirements diagnosis, energy with clinical of imbalance already time energy are the infants at Most growth. malnourished rapid to due requirements of level a at transthyretin; different TTR, *Significantly group; 1 reference RG, group; fibrosis cystic CF, 49 266 18 121 CRP Fibrinogen 198 Haptoglobin Cp TTR Transferrin (mg/dl) levels Plasma 1. Table ttso hs ainsms eicue mn the among and included prognosis evolution, be CF must the in survival patients involved factors these main of status ye eepromduigteStudent’s the using performed were lyses Dfult,Boinic,Beo ie,Agniaand immuno- Argentina Aires, UK) radial Site, kits Buenos Binding single available Biocientifica, commercially by using (Diffuplate, by and measured collected techniques (TTR), diffusion protein were were C-reactive transthyretin fibrinogen haptoglobin, samples Pedro Transferrin, (Cp), from Blood patients. ceruloplasmin Service years, fasting 10 Hospital. Nutrition to from the months Elizalde 3 at aged de assisted CF with were children girls) who non-hospitalized 5 17 and on boys (12 performed was study The in CF. (TAC), from suffering capacity and children antioxidant non-hospitalized inflammation total to and related status, nutritional proteins plasma specific mine nixdns nldn aood,hydroxycinnamates, antioxidants plasma flavonoids, and hydrophilic carotenoids and including lipophilic both antioxidants, to applicable assay ization ik xs ewe rgeso fC ugdsaeand disease lung CF of progression stress oxidative between exist links inadiflmaincniust as oto the of pathology most this cause in to mortality continues and inflammation morbidity and tion bandfo aet eoercutn h ainsinto patients the recruiting was study. before consent the parents informed and from Aires, obtained Buenos of University the equivalents) p euolsi;CP -ecieprotein. C-reactive CRP, ceruloplasmin; Cp, hrfr,ti rlmnr td a ie odeter- to aimed was study preliminary this Therefore, oevr iiu yl fara btuto,infec- obstruction, airway of cycle vicious a Moreover, h eotwsapoe yteEhc omte from Committee Ethics the by approved was report The https://www.cambridge.org/core M (3) Trolox ; tde iceia aaeesadttlantioxidant total and parameters biochemical Studied . ma ausadsadr deviation) standard and values (mean (2,4–8) (9,10) aeiladmethods and Material enS enSD Mean SD Mean (11) hrfr,tesuyo h nutritional the of study the Therefore, . 1 ...... (3) 310 1 0 91* 145 21 87 3 18 9* 2* 53 86 1* . A a eemndb decolor- a by determined was TAC . https://doi.org/10.1017/S0029665110001771 hsiblnecnb explained be can imbalance This . aaiy(TAC) capacity FRG CF P < 0 . IPaddress: ...... 1 41 04 101 0 7 0 289 5251222 . 01. < (12,13) < 285 > 170.106.40.219 0 0(eial value) (desirable 40 . dsrbevalue) (desirable 2 ...... 80 98 14615 06 020 dsrbevalue) (desirable 0 ttsia ana- Statistical . t test. (2) imre rfiei ytcfirss355 fibrosis cystic in profile Biomarker Numerous . , on 26 Sep2021 at04:15:58 . . . . . 04 6 9 6 0 rti rcinfudi hlrnsfeigfo CF from suffering this children of in levels TNF found be concentration fraction by the protein could explain inhibited could is concentration outcome synthesis this TTR transferrin Moreover, CF), children reduced. in from observed (situations suffering inflammation chronic and elh hlrno ohsxsadasmlraerange age similar a and sexes both group) (reference of children Student’s healthy the using compared t were and deviation standard ncide trs fCVD status of inflammatory risk an at confirm children would in result this group; pectively. fptet xeddtedsrbevle o fibrinogen for values desirable 50% the and the to 23 ( exceeded that relation highlighted patients in be patients of should CF It in group. higher reference found were levels hog h eeso 3 n 4 rcin n the and fractions lymphocyte-related C4c T altered and (a was C3c deaminase enzyme) adenosine of of suf- evaluated levels system, activity children immune the in the that group through suggest working CF from our fering by findings Previous children. healthy u dl ainsso ihrtasernlvl than levels transferrin pathology, higher this show from patients suffering children adult adults in but reported viour -eciepoentgte ihlwrvle fHDL- and of fibrinogen values of lower levels with (27 higher cholesterol together showed protein group C-reactive CF The oyfo elh hlrno ohsxsadasimilar a deficiency and 20 protein below sexes ( values group) both TTR showing labora- (reference of our range children in age healthy obtained patients data CF from with in tory comparison found in were 1) TTR) (Table and (transferrin whole. reason proteins a the as is population range That the biomarkers. age analyzed studied we by the why all divided and in was observed years tested months–2 population (3 the When the in unpublished assessed Insani, (M. children control results). healthy reference periodic for in TAC hospital same obtained values bibliography. was desirable international value the by with provided compared were concentrations T ausfudi hspeiiayrpr ugse an suggested report preliminary status this nutritional plasma in abnormal low found towards values tendency TTR the and concentration ferrin namtr yoie,sc sI-,I- n TNF these and pro- IL-1 of by IL-6, induced synthesis as be such to increased inflam- shown cytokines, been concomitant the inflammatory has a proteins fact, phase to in acute related status; be matory could levels plasma < etwt ulse aaotie norlbrtr from laboratory our in obtained data published with test 285 TAC oe auso h urtoa ttsrltdplasma status-related nutritional the of values Lower lsafatosrslswr xrse as expressed were results fractions Plasma nadto,teosre nraei padhaptoglobin and Cp in increase observed the addition, In , subjectto theCambridgeCore termsofuse,available at . gd)adCratv rti ( protein C-reactive and mg/dl) 0 (12,13) (18) nauepaeratossc sinfections as such reactions phase acute In . a infiatylwri Fptet hnin than patients CF in lower significantly was . 8( (14,15) (16) SD oee,bt padhaptoglobin and Cp both However, . (17) 10 -eciepoenadfibrinogen and protein C-reactive ; Discussion oevr h erae trans- decreased the Moreover, . . Results )m/l hni h reference the in than mg/dl) 3) > (16) er) odfeecswere differences no years), 2 (20) T hw h aebeha- same the shows TTR . . P gd,wihi eae to related is which mg/dl, 0 oevr h described the moreover, ; < 0 . 1,5%o children of 50% 01), < 0 . gd) res- mg/dl), 2 X (19) a with (19) . b ; . https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 5 .H Slobodianik H. N. 356 needn ikfco o V nti population this in CVD another for as factor considered be risk could Cp independent of activity pro-oxidant namto sa vn curn ro oifcinin that infection reported to have prior studies occurring CF event with several patients an hand, is other inflammation the On il o obdt n otlt nti ies,i parti- stress is oxidative disease, of levels this high in respon- to mortality organ vulnerable and cularly main morbidity the for lung, sible The CF. of pathophysiology .S,A .adM .slce h ains bandthe manu- obtained the of patients, elaboration the the selected in script. B., F. S. participated M. and results. and samples of F. biochemical A. discussion performed of S., P. I. and P. conflict of and analysis no F. University S. determinations, declare M. the S., authors H. N. by The interest. supported (B074). Aires partially Buenos was work This these of quality life and survival the being improve patients. actions and nutri- these to nutritional appropriate therapies, able patient’s design pharmacological to the and tional and analyse evolution to inclusion inflammatory us early This allow the patients. include CF in would to non-hospitalized parameters need of functional days, evaluation the and 1–2 explain biochemical TTR could these days, days) 2–4 7–10 and haptoglobin (transferrin inflammation both status to nutritional related fractions plasma half-life nkyciia ucmsi CF in interventions outcomes nutritional clinical of key effects on the are examine studies to Long-term nutritional thera- needs. required individual specific for to with adjusted possibilities oxidant– support concomitant that the several interventions disease in raise peutic complex abnormalities balance (a the antioxidant CF care); in clinical rates on requires survival effect important and an growth has management nutritional Careful function. deterioration their the and/or to cells due the immune system the explain immune of could the and of status depression would inflammatory concentration the Cp plasma exacerbate increased an with comitant .Kltk enad 20)Ntiinlcalne of challenges Nutritional (2001) D Reinhardt inflam- & Chronic S (2008) Koletzko M 3. Berger & J Chmiel D, Nichols 2. .RsesenB utn R(98 h igoi fcystic of diagnosis The (1998) GR Cutting & BJ Rossenstein 1. xdtv tesmypa infiatrl nthe in role significant a play may stress Oxidative hs rlmnr eut efre nlwspecific low on performed results preliminary These h iiihdTCi o-optlzdcide con- children non-hospitalized in TAC diminished The nat ihcsi fibrosis. and cystic inter- with infants in alterations lung: fibrosis cystic signaling. intracellular the in mation boi.Acnessstatement. consensus A fibrosis. https://www.cambridge.org/core (22) . Acknowledgements . https://doi.org/10.1017/S0029665110001771 Conclusions References lnRvAlryImmunol Allergy Rev Clin . IPaddress: al u Dev Hum Early (23) Pediatr J . 170.106.40.219 132 65 589–595. , S53–S61. , , on 4 146–162. , 26 Sep2021 at04:15:58 (10,23) (21) . . 0 yr ,RfiN rc R Tracy N, Rifai G, Myers 20. and Questions Proteins: (2000) B Zawta & B Trefz G, Topfer 19. 3 atnA,WieT,CosCE Cross TB, White AM, Cantin 23. Martı & JM Freyssinet M, E Rottner Ehrenwal 22. C, Mukhopadhyay PL, Fox 21. 8 metM ilrJ rweA 18)Poenabnorm- Protein (1987) AJ Crowle & JL Miller M, Emmett 18. S Barbeito MS, Feliu P, Perris 17. 5 ei S&SooinkN 19)Vlrsd Referencia de Valores (1992) NH Slobodianik & MS Feliu 15. 6 negekY&YugV(94 rntyei (Prealbumin) Transthyretin (1994) V Young & Y Ingengleek 16. 4 ei S&SooinkN 19)Vlrsd Referencia de Valores (1992) NH Slobodianik & MS Feliu 14. A Proteggente N, Pellegrini R, Re 13. 2 ilrN,Rc-vn A aisNJ Davies CA, Rice-Evans NJ, Miller 12. 1 acn ,CroaaA eeasG (1965) GF Heremans & AO plasma Carbonara Total (2000) G, C Mancini Grenier 11. & VL Grey LC, Lands 10. .Cni M ht B rs CE Cross TB, White AM, Cantin 9. .Pnhr B&DreP 20)Ptoeei fmal- of Pathogenesis (2000) PR Durie & PB Pencharz 8. .DdeJ uc 20)Csi boi:nutritional fibrosis: Cystic (2006) D Turck & JA Dodge 7. and Nutrition (2002) E Cirdei J D, Moraru Navarro DT, Anton & 6. A Munck R, Hankard 5. J Oses Sarria G, Bozano Prieto M, Arias Molina 4. , subjectto theCambridgeCore termsofuse,available at tal et nwr o eia igoi.Gray oh Diagnosis Roche Germany: GmbH. Diagnosis. Medical for Answers ncsi fibrosis. cystic in euolsi n adoaclrdisease. Med cardiovascular and Ceruloplasmin Cardiovascular and Inflammation of Disease. Markers on Workshop lte nautrsiaoydsrs ydoe tuberculosis, syndrome, sera. distress fibrosis respiratory cystic and adult in alities nsso h oiu namtr yl ncsi fibrosis. cystic in cycle inflammatory Res noxious Respir the of anisms se fracciones de 4 ocnrtosadaeoiedaiaeatvt of study. activity preliminary deaminase fibrosis: Soc cystic adenosine with and children concentrations C4c implications. 14 nutritional disease: and health in nin se fracciones de Bioline ciiyapyn nipoe BSrdclcto decolor- cation radical assay. ABTS ization improved an applying neo- activity premature in status applica- antioxidant its the nates. and monitoring capacity to antioxidant tion measuring for method muohmclqattto fatgnb igeradial single by antigen of immunodiffusion. quantitation Immunochemical fibrosis. 81–87. Cystic in capacity antioxidant 15–31. ncsi boi.Cnlsosfo h Fantioxidant CF the from Maryland. Conclusions Bethesa, fibrosis. workshop, cystic in 387–394. urto ncsi boi n t treatment. its and fibrosis cystic in nutrition enterol management. and consequences fibrosis. cystic in growth 575–581. considerations. nutritional fibrosis: Cystic o e a Lasi Nat fibrosis. Med cystic Soc in therapy nutritional complex ˜ 495–533. , os. . 67 28 lnSci Clin caBioquı Acta OE,E59. (OCE), 1735–1744. , 20 6 Circulation 6–8. , 531–546. , 10 23–34. , reRdcBo Med Biol Radic Free ´ 84 ´ ia especı ricas ia euiia netdo enutricio de estudios en utilidad de ricas 407–412. , ´ reRdcBo Med Biol Radic Free Immunochemistry .Latinoam m. 110 110 801–806. , rcScEpBo Med Biol Exp Soc Proc 545–549. , omRes Horm ´ cse nin en ficas tal et tal et xxvi etPatRsCi Gastro- Clin Res Pract Best reRdcBo Med Biol Radic Free tal et tal et tal et tal et 20)Mlurto and Malnutrition (2006) . ´ 319–327. , 26 20)SrmCcand C3c Serum (2008) . 58 2 e C(09 Mech- (2009) MC nez ˜ 235–254. , s sui preliminar. Estudio os. 1231–1237. , up.1 S16–S20. 1, Suppl. , 20)CDC/AHA (2004) . eit Pulmonol Pediatr 20)Antioxidants (2007) . 20)Antioxidants (2007) . tal et 42 19)Antioxidant (1999) . nEpPediatr Esp An 15–31. , 19)Anovel A (1993) . reRdcBiol Radic Free nuRvNutr Rev Annu tal et e e Chir Med Rev lnNutr Clin tal et 184 rcNutr Proc (2000) . 74–82. , (2001) . ´ n,en 29 42 19 54 , , , ,